News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Cipher Pharmaceuticals Reports Fiscal 2006 Year-end Results
March 8, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
MISSISSAUGA, Ontario, March 7, 2007 – Cipher Pharmaceuticals Inc. (TSX: DND) today announced its financial and operational results for the fourth quarter and fiscal year ended December 31, 2006.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Funding
Veradermics Gets $150M Series C To Advance Hair Regrowth Pill
October 16, 2025
·
2 min read
·
Tristan Manalac
Layoffs
Q3 Layoffs Up 280% YOY With CSL, Merck, Novo’s Restructurings
October 16, 2025
·
4 min read
·
Angela Gabriel
Rare diseases
Novo Offers up to $2.1B for Omeros’ Complement Drug To Expand Rare Disease Work
October 15, 2025
·
2 min read
·
Dan Samorodnitsky
Funding
Pelage Pharmaceuticals Raises $120 Million To Grow Hair Loss Program
October 15, 2025
·
2 min read
·
Dan Samorodnitsky